Insight Capital Research & Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Insight Capital Research & Management’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-9,213	Closed	-$674K	–	167
2014 Q1	$674K	Sell	9,213 -239	-3%	-$17.8K	0.16%	107
2013 Q4	$651K	Sell	9,452 -5,480	-37%	-$355K	0.15%	117
2013 Q3	$926K	Sell	14,932 -36,407	-71%	-$2.2M	0.22%	100
2013 Q2	$2.48M	Buy	+51,339	New	+$2.52M	0.64%	55

Other funds holding CBST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Insight Capital Research & Management's CBST Position: Q2 2014 in Review

Insight Capital Research & Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 9,213 shares — an estimated $674K sold.

Insight Capital Research & Management first reported a position in CBST in Q2 2013 and held it in 4 quarters. The position peaked at $2.48M in Q2 2013. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

Insight Capital Research & Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
Insight Capital Research & Management sold 9,213 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $674K.
Insight Capital Research & Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
Insight Capital Research & Management's CUBIST PHARMACEUTICALS INC position peaked at $2.48M in Q2 2013.
270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Insight Capital Research & Management's 13F filing for Q2 2014, filed 13 Aug 2014.